Cardinal Health (CAH) Stock Forecast & Price Target

Compare

2,228 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CAH Analyst Ratings

Strong Buy

10 Buy

2 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Cardinal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CAH Stock 12 Month Forecast

Average Price Target

$173.33

▲(7.38%Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $173.33 with a high forecast of $183.00 and a low forecast of $156.00. The average price target represents a 7.38% change from the last price of $161.41.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"95":"$95","184":"$184","117.25":"$117.3","139.5":"$139.5","161.75":"$161.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":183,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$183.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":173.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$173.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":156,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$156.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[95,117.25,139.5,161.75,184],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,155.25,157.3846153846154,159.51923076923077,161.65384615384616,163.78846153846155,165.92307692307693,168.05769230769232,170.19230769230768,172.32692307692307,174.46153846153845,176.59615384615384,178.73076923076923,180.8653846153846,{"y":183,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,155.25,156.64076923076922,158.03153846153847,159.4223076923077,160.81307692307692,162.20384615384617,163.5946153846154,164.98538461538462,166.37615384615384,167.7669230769231,169.15769230769232,170.54846153846154,171.9392307692308,{"y":173.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,155.25,155.30769230769232,155.3653846153846,155.42307692307693,155.48076923076923,155.53846153846155,155.59615384615384,155.65384615384616,155.71153846153845,155.76923076923077,155.82692307692307,155.8846153846154,155.94230769230768,{"y":156,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":97.53,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.54,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.1,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.31,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.46,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.21,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.5,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":117.33,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.21,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":129,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.13,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.53,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.25,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$183.00

Average Price Target$173.33

Lowest Price Target$156.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$169

Buy

4.70%

Upside

Upgraded

06/12/25

Cardinal Health's strong operational performance and strategic growth initiatives are offset by financial risks due to negative equity and high leverage. The stock's valuation is relatively high, and while technical indicators show stability, the company's ability to manage tariff impacts and maintain growth will be critical for future performance.

Erin WrightMorgan Stanley

Morgan Stanley

$166→$181

Buy

12.14%

Upside

Reiterated

06/13/25

Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Apellis Pharmaceuticals (NASDAQ: APLS)

Allen LutzBank of America Securities

Bank of America Securities

$170→$180

Buy

11.52%

Upside

Reiterated

06/13/25

Cardinal Health's Strong Execution and Industry Tailwinds Support Buy Rating with Potential for Double-Digit EPS Growth

Daniel GrosslightCiti

Citi

$157→$170

Hold

5.32%

Upside

Reiterated

06/13/25

Cardinal Health price target raised to $170 from $157 at CitiCardinal Health price target raised to $170 from $157 at Citi

Charles RhyeeTD Cowen

TD Cowen

$162→$183

Buy

13.38%

Upside

Reiterated

06/13/25

TD Cowen Keeps Their Buy Rating on Cardinal Health (CAH)

Stephen BaxterWells Fargo

Wells Fargo

$179

Buy

10.90%

Upside

Reiterated

06/12/25

Cardinal Health's Strong Growth Prospects and Enhanced Shareholder Value Drive Buy Rating

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$175→$180

Buy

11.52%

Upside

Reiterated

06/12/25

Buy Recommendation for Cardinal Health Driven by Strong Financial Outlook and Strategic Initiatives

Steven ValiquetteMizuho Securities

Mizuho Securities

$150→$161

Buy

-0.25%

Downside

Reiterated

06/06/25

Cardinal Health (CAH) Gets a Buy from Mizuho Securities

Michael ChernyLeerink Partners

Leerink Partners

$173→$177

Buy

9.66%

Upside

Reiterated

06/03/25

Leerink Partners Remains a Buy on Cardinal Health (CAH)

Eric ColdwellRobert W. Baird

Robert W. Baird

$170→$181

Buy

12.14%

Upside

Reiterated

05/28/25

Cardinal Health (CAH) Gets a Buy from Robert W. Baird

Lisa GillJ.P. Morgan

J.P. Morgan

$156

Hold

-3.35%

Downside

Reiterated

05/12/25

Analysts Offer Insights on Healthcare Companies: Flora Growth (NASDAQ: FLGC), Cardinal Health (NYSE: CAH) and Zevra Therapeutics (NASDAQ: ZVRA)

Kristina RuggeriArgus Research

Argus Research

$148→$162

Buy

0.37%

Upside

Reiterated

05/05/25

Argus Research Sticks to Its Buy Rating for Cardinal Health (CAH)

Kevin CaliendoUBS

UBS

$150→$170

Buy

5.32%

Upside

Reiterated

04/29/25

Cardinal Health price target raised to $160 from $150 at UBSCardinal Health price target raised to $160 from $150 at UBS

Brian TanquilutJefferies

Jefferies

$125→$150

Buy

-7.07%

Downside

Upgraded

02/05/25

Cardinal Health's Growth Potential Under New Management: Buy Rating Backed by Strong Earnings and Strategic AcquisitionsWe U/G CAH to Buy given: 1) new mgmt's impressive EPS track record with NT cushion in F2H25 guide; 2) our expectation for a +10-14% LT EPS growth target when they refresh CAH's LRP ('26+) in June; 3) our belief that multiple expansion will continue as growth expectations are validated; 4) muted real exposure relative to Large Cap Srvcs neighbors on H/C DC overhangs. PT to $150, 1.8x PEG on CY25E & low-end of our anticipated LRP. Given LT While LT Strategy is Shaping Up Nicely. Given years of earnings misses & fundamental challenges at CAH we've maintained a cautious stance despite stock appreciation & valuation lift as the new team has executed. With 10 quarters down and only one narrow Cons.

George HillDeutsche Bank

Deutsche Bank

$124→$131

Hold

-18.84%

Downside

Reiterated

01/31/25

Cardinal Health (CAH) PT Raised to $131 at Deutsche BankDeutsche Bank analyst George Hill raised the price target on Cardinal Health (NYSE: CAH) to $131.00 (from $124.00) while maintaining a Hold rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$169

Buy

4.70%

Upside

Upgraded

06/12/25

Erin WrightMorgan Stanley

Morgan Stanley

$166→$181

Buy

12.14%

Upside

Reiterated

06/13/25

Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Apellis Pharmaceuticals (NASDAQ: APLS)

Allen LutzBank of America Securities

Bank of America Securities

$170→$180

Buy

11.52%

Upside

Reiterated

06/13/25

Cardinal Health's Strong Execution and Industry Tailwinds Support Buy Rating with Potential for Double-Digit EPS Growth

Daniel GrosslightCiti

Citi

$157→$170

Hold

5.32%

Upside

Reiterated

06/13/25

Cardinal Health price target raised to $170 from $157 at CitiCardinal Health price target raised to $170 from $157 at Citi

Charles RhyeeTD Cowen

TD Cowen

$162→$183

Buy

13.38%

Upside

Reiterated

06/13/25

TD Cowen Keeps Their Buy Rating on Cardinal Health (CAH)

Stephen BaxterWells Fargo

Wells Fargo

$179

Buy

10.90%

Upside

Reiterated

06/12/25

Cardinal Health's Strong Growth Prospects and Enhanced Shareholder Value Drive Buy Rating

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$175→$180

Buy

11.52%

Upside

Reiterated

06/12/25

Buy Recommendation for Cardinal Health Driven by Strong Financial Outlook and Strategic Initiatives

Steven ValiquetteMizuho Securities

Mizuho Securities

$150→$161

Buy

-0.25%

Downside

Reiterated

06/06/25

Cardinal Health (CAH) Gets a Buy from Mizuho Securities

Michael ChernyLeerink Partners

Leerink Partners

$173→$177

Buy

9.66%

Upside

Reiterated

06/03/25

Leerink Partners Remains a Buy on Cardinal Health (CAH)

Eric ColdwellRobert W. Baird

Robert W. Baird

$170→$181

Buy

12.14%

Upside

Reiterated

05/28/25

Cardinal Health (CAH) Gets a Buy from Robert W. Baird

Lisa GillJ.P. Morgan

J.P. Morgan

$156

Hold

-3.35%

Downside

Reiterated

05/12/25

Analysts Offer Insights on Healthcare Companies: Flora Growth (NASDAQ: FLGC), Cardinal Health (NYSE: CAH) and Zevra Therapeutics (NASDAQ: ZVRA)

Kristina RuggeriArgus Research

Argus Research

$148→$162

Buy

0.37%

Upside

Reiterated

05/05/25

Argus Research Sticks to Its Buy Rating for Cardinal Health (CAH)

Kevin CaliendoUBS

UBS

$150→$170

Buy

5.32%

Upside

Reiterated

04/29/25

Cardinal Health price target raised to $160 from $150 at UBSCardinal Health price target raised to $160 from $150 at UBS

Brian TanquilutJefferies

Jefferies

$125→$150

Buy

-7.07%

Downside

Upgraded

02/05/25

George HillDeutsche Bank

Deutsche Bank

$124→$131

Hold

-18.84%

Downside

Reiterated

01/31/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

1 Month

xxx

Success Rate

10/15 ratings generated profit

Average Return

+3.40%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +3.40% per trade.

3 Months

xxx

Success Rate

12/15 ratings generated profit

Average Return

+6.19%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +6.19% per trade.

1 Year

Kevin CaliendoUBS

Success Rate

15/15 ratings generated profit

Average Return

+27.20%

reiterated a buy rating 2 months ago

Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +27.20% per trade.

2 Years

xxx

Success Rate

15/15 ratings generated profit

Average Return

+58.62%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +58.62% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CAH Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CAH has received 19 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. CAH average Analyst price target in the past 3 months is 173.33.

Each month's total comprises the sum of three months' worth of ratings.

CAH Financial Forecast

CAH Earnings Forecast

Next quarter’s earnings estimate for CAH is $2.01 with a range of $1.93 to $2.07. The previous quarter’s EPS was $2.35. CAH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.02% of the time in the same period. In the last calendar year CAH has Outperformed its overall industry.

CAH Sales Forecast

Next quarter’s sales forecast for CAH is $60.91B with a range of $60.09B to $62.00B. The previous quarter’s sales results were $54.88B. CAH beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year CAH has Outperformed its overall industry.

CAH Stock Forecast FAQ

What is CAH’s average 12-month price target, according to analysts?

Based on analyst ratings, Cardinal Health’s 12-month average price target is 173.33.

What is CAH’s upside potential, based on the analysts’ average price target?

Cardinal Health has 7.38% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CAH a Buy, Sell or Hold?

Cardinal Health has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.

What is Cardinal Health’s price target?

The average price target for Cardinal Health is 173.33. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $183.00 ,the lowest forecast is $156.00. The average price target represents 7.38% Increase from the current price of $161.41.

What do analysts say about Cardinal Health?

Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of CAH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Cardinal Health (CAH) Stock Forecast & Price Target

CAH Analyst Ratings

CAH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cardinal Health

CAH Analyst Recommendation Trends

CAH Financial Forecast

CAH Earnings Forecast

CAH Sales Forecast

CAH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts